Migraine Companies

ID: MRFR/Pharma/1756-HCR

85 Pages

Kinjoll Dey

September 2025

At the forefront of neurological healthcare, Migraine companies specialize in innovative solutions. From research to treatment, these organizations focus on developing therapies that address the complexities of migraines, providing relief for patients. Their commitment lies in advancing migraine care and improving overall neurological well-being.

Migraine Market Research Report - Forecast To 2032 Infographic

Summary Table of Contents Segmentation Infographic

Top Industry Leaders in the Migraine Market

Migraine Key Companies

Latest Migraine Companies Update

Pfizer acquires Biohaven in 2023 strategic move strengthens Pfizer's presence in the migraine market, particularly with Biohaven's flagship CGRP inhibitor, Nurtec ODT.

Eli Lilly partners with Tonix for nasal spray triptans collaboration expands Lilly's migraine portfolio with Tosymra and Zembrace SymTouch, offering alternative delivery options for patients.

Collaborations between pharmaceutical companies, device manufacturers, and digital health platforms are fostering innovation and driving market growth.

List of Migraine Key Companies in the Market

Sanofi SA

Abbott Laboratories

Teva Pharmaceutical Industries Limited

Allergan Plc

Pfizer Inc

AstraZeneca

Johnson & Johnson

Endo International Plc

GlaxoSmithKline Plc

Impax Laboratories.